RAD21 Cohesin Complex Component

Key regulator of sister chromatid cohesion, DNA repair, and transcriptional control

Gene Information Card

Symbol RAD21
Full Name RAD21 Cohesin Complex Component
Gene Type Protein coding
Chromosomal Location 8q24.11
NCBI Gene ID 5885 ncbi.nlm.nih.gov/gene/5885
Ensembl ID ENSG00000164754
UniProt ID O60216
OMIM ID 606462
HGNC ID 9811
Aliases SCC1, MCD1, NXP1, hHR21, KIAA0078

Description

RAD21 encodes a key component of the cohesin complex, which mediates sister chromatid cohesion during mitosis and meiosis, facilitates DNA double-strand break repair via homologous recombination, and regulates gene expression through chromatin looping. Mutations in RAD21 cause Cornelia de Lange syndrome type 4 (CdLS4) and are associated with various cancers, including colorectal and breast cancer.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Cornelia de Lange syndrome 4 (CdLS4) Loss-of-function mutations impair cohesin complex assembly, leading to developmental defects OMIM #614701; multiple case reports
Colorectal cancer Somatic mutations and reduced expression disrupt cohesion and DNA repair, promoting genomic instability COSMIC; TCGA data
Breast cancer RAD21 overexpression correlates with poor prognosis; altered cohesion contributes to aneuploidy ClinVar; literature
Acute myeloid leukemia (AML) Recurrent deletions and mutations in RAD21 are found in AML, impairing hematopoiesis COSMIC; ClinVar

Expression Profile

Tissue Expression
Tissue nTPM level
Testis 28.5 High
Bone marrow 18.2 Medium
Lymph node 15.1 Medium
Brain 8.3 Low
Liver 6.7 Low
Cell Line Expression
Cell Line nTPM Notes
K562 (leukemia) 22.4 High expression
HeLa (cervical) 19.8 Medium expression
HepG2 (liver) 7.2 Low expression
MCF7 (breast) 14.5 Medium expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1846C>T (p.Arg616*) Nonsense <0.1% Loss of function; truncation of C-terminal domain
c.1430A>G (p.Tyr477Cys) Missense <0.01% Impaired cohesin loading
c.1135_1136del (p.Leu379fs) Frameshift <0.1% Loss of function; premature termination
c.1685G>A (p.Arg562Gln) Missense <0.01% Reduced DNA repair efficiency
Mutation functional classification

Loss of Function (LOF)

Nonsense, frameshift, and splice-site mutations that truncate or destabilize RAD21, leading to haploinsufficiency or non-functional protein. Associated with CdLS4 and cancer.

Gain of Function (GOF)

Not well documented; overexpression in some cancers may confer proliferative advantage but not a classical gain-of-function mutation.

Dominant Negative (DN)

Missense mutations (e.g., p.Tyr477Cys) that disrupt cohesin complex assembly without complete loss of wild-type allele, interfering with normal function.

Pathways

Cell cycle – sister chromatid cohesion (Reactome: R-HSA-1500620)
Homologous recombination repair of double-strand breaks (Reactome: R-HSA-5693565)
Cohesin loading onto chromatin (Reactome: R-HSA-2470946)

Protein Summary

RAD21 is a 631-amino acid nuclear phosphoprotein that serves as the central subunit of the cohesin complex, forming a ring-like structure with SMC1A, SMC3, and STAG proteins. It is essential for sister chromatid cohesion from S phase through anaphase, and is cleaved by separase at the metaphase-to-anaphase transition. Beyond mitosis, RAD21 participates in DNA damage repair by facilitating homologous recombination and influences gene expression by mediating long-range chromatin interactions. Post-translational modifications, including phosphorylation and SUMOylation, regulate its stability and function.

Related Products

Product name Cat.No. Species Gene ID
RAD21L1 Knockout HEK293 Cell Line EDJ-KQ14985 Human 642636 Details Get a Quote
RAD21L1 Knockout HeLa Cell Line EDJ-KQ60530 Human 642636 Details Get a Quote
RAD21L1 Knockout A-549 Cell Line EDJ-KQ69000 Human 642636 Details Get a Quote
RAD21L1 Knockout HCT 116 Cell Line EDJ-KQ77358 Human 642636 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: